This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Naleway, A L Articles by McCarty, D J Search for Related Content PubMed PubMed Citation Articles by Naleway, A L Articles by McCarty, D J Social Bookmarking                         What's this?

Epidemiology of systemic lupus erythematosus in rural Wisconsin

Epidemiology Research Center, Marshfield Clinic Research Foundation, Marshfield, WI, USA, allison.naleway{at}kpchr.org

M E Davis

Department of Rheumatology, Marshfield Clinic, Marshfield, WI, USA

R T Greenlee

Epidemiology Research Center, Marshfield Clinic Research Foundation, Marshfield, WI, USA

D A Wilson

Department of Rheumatology, Marshfield Clinic, Marshfield, WI, USA

D J McCarty

Epidemiology Research Center, Marshfield Clinic Research Foundation, Marshfield, WI, USA

We investigated the epidemiology of systemic lupus erythematosus (SLE) in the Marshfield Epidemiologic Study Area (MESA), a defined rural region where nearly all residents obtain their health care from a large clinic system. Computerized medical records were searched to identify MESA residents diagnosed with SLE from 1991 through 2001. Medical records were manually reviewed for all selected patients to identify cases of SLE using the 1982 revised American College of Rheumatology criteria. Patients with 4 criteria were classified as definite SLE. Age- and gender- specific SLE incidence rates (1991-2001), the population prevalence rate of SLE on 31 December 2001 and survival rates were calculated. We identified 117 MESA residents with definite SLE. The average age-adjusted incidence of definite SLE was 5.1 per 100 000 per year (95% CI: 3.6, 6.6) and the age-adjusted population prevalence was 78.5 per 100 000 (95% CI: 59.0, 98.0). The mean age at diagnosis among the 44 incident cases was 51.7 years (range: 14-90 years). Positive anti-nuclear antibody (ANA), hematologic abnormalities, arthritis and renal disease were common at diagnosis. Five- and 10-year survival rates were 88% and 76%, respectively. Epidemiologic characteristics of SLE in this rural Caucasian population are generally similar to those reported by other US studies. One notable difference is a relatively high incidence of SLE in older adults.

Key Words: incidence • prevalence • survival • systemic lupus erythematosus

Lupus, Vol. 14, No. 10, 862-866 (2005)
DOI: 10.1191/0961203305lu2182xx


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. Bernatsky, L. Joseph, C. A. Pineau, R. Tamblyn, D. E. Feldman, and A. E. Clarke A population-based assessment of systemic lupus erythematosus incidence and prevalence results and implications of using administrative data for epidemiological studies Rheumatology, December 1, 2007; 46(12): 1814 - 1818. [Abstract] [Full Text] [PDF]

				N Danchenko, J A Satia, and M S Anthony Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden Lupus, May 1, 2006; 15(5): 308 - 318. [Abstract] [PDF]